Cyanobacteria Secondary Metabolites as Biotechnological Ingredients in Natural Anti-Aging Cosmetics: Potential to Overcome Hyperpigmentation, Loss of Skin Density and UV Radiation-Deleterious Effects.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101213729 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-3397 (Electronic) Linking ISSN: 16603397 NLM ISO Abbreviation: Mar Drugs Subsets: MEDLINE
    • Publication Information:
      Original Publication: Basel, Switzerland : MDPI, [2003]-
    • Subject Terms:
    • Abstract:
      The loss of density and elasticity, the appearance of wrinkles and hyperpigmentation are among the first noticeable signs of skin aging. Beyond UV radiation and oxidative stress, matrix metalloproteinases (MMPs) assume a preponderant role in the process, since their deregulation results in the degradation of most extracellular matrix components. In this survey, four cyanobacteria strains were explored for their capacity to produce secondary metabolites with biotechnological potential for use in anti-aging formulations. Leptolyngbya boryana LEGE 15486 and Cephalothrix lacustris LEGE 15493 from freshwater ecosystems, and Leptolyngbya cf. ectocarpi LEGE 11479 and Nodosilinea nodulosa LEGE 06104 from marine habitats were sequentially extracted with acetone and water, and extracts were analyzed for their toxicity in cell lines with key roles in the skin context (HaCAT, 3T3L1, and hCMEC). The non-toxic extracts were chemically characterized in terms of proteins, carotenoids, phenols, and chlorophyll a, and their anti-aging potential was explored through their ability to scavenge the physiological free radical superoxide anion radical (O2•−), to reduce the activity of the MMPs elastase and hyaluronidase, to inhibit tyrosinase and thus avoid melanin production, and to block UV-B radiation (sun protection factor, SPF). Leptolyngbya species stood out for anti-aging purposes: L. boryana LEGE 15486 presented a remarkable SPF of 19 (at 200 µg/mL), being among the best species regarding O2•− scavenging, (IC50 = 99.50 µg/mL) and also being able to inhibit tyrosinase (IC25 = 784 µg/mL), proving to be promising against UV-induced skin-aging; L. ectocarpi LEGE 11479 was more efficient in inhibiting MMPs (hyaluronidase, IC50 = 863 µg/mL; elastase, IC50 = 391 µg/mL), thus being the choice to retard dermal density loss. Principal component analysis (PCA) of the data allowed the grouping of extracts into three groups, according to their chemical composition; the correlation of carotenoids and chlorophyll a with MMPs activity (p < 0.01), O2•− scavenging with phenolic compounds (p < 0.01), and phycocyanin and allophycocyanin with SPF, pointing to these compounds in particular as responsible for UV-B blockage. This original survey explores, for the first time, the biotechnological potential of these cyanobacteria strains in the field of skin aging, demonstrating the promising, innovative, and multifactorial nature of these microorganisms.
    • References:
      Microorganisms. 2020 Feb 21;8(2):. (PMID: 32098255)
      Acta Biomater. 2020 Oct 1;115:299-316. (PMID: 32853810)
      Food Sci Nutr. 2016 Jan 20;4(5):753-8. (PMID: 27625779)
      Mar Drugs. 2012 Dec 10;10(12):2766-81. (PMID: 23222802)
      Arch Pharm Res. 2005 Oct;28(10):1152-5. (PMID: 16276971)
      Pathol Biol (Paris). 2014 Apr;62(2):91-5. (PMID: 24650524)
      Biotechnol Adv. 2019 May - Jun;37(3):422-443. (PMID: 30797095)
      Molecules. 2021 Jan 02;26(1):. (PMID: 33401768)
      Bioresour Technol. 2019 Feb;273:103-113. (PMID: 30419445)
      Bull Environ Contam Toxicol. 2009 Oct;83(4):509-15. (PMID: 19629363)
      Int J Cosmet Sci. 2008 Oct;30(5):353-60. (PMID: 18822041)
      Skin Pharmacol Physiol. 2010;23(4):201-12. (PMID: 20215813)
      J Enzyme Inhib Med Chem. 2021 Dec;36(1):1829-1838. (PMID: 34353202)
      J Biosci Bioeng. 2016 Mar;121(3):345-8. (PMID: 26296532)
      Int J Biochem Cell Biol. 2002 Dec;34(12):1508-12. (PMID: 12379270)
      Lett Appl Microbiol. 2018 Sep;67(3):314-320. (PMID: 29947423)
      Lancet. 1991 Jan 26;337(8735):211-4. (PMID: 1670850)
      BMC Complement Altern Med. 2016 Dec 13;16(1):515. (PMID: 27964734)
      J Enzyme Inhib Med Chem. 2019 Dec;34(1):279-309. (PMID: 30734608)
      Bioresour Technol. 2010 Oct;101(19):7587-91. (PMID: 20494571)
      J Cosmet Laser Ther. 2016 Oct;18(5):301-10. (PMID: 26963365)
      Anal Chim Acta. 2007 Feb 12;584(1):50-6. (PMID: 17386584)
      Br J Dermatol. 2019 Mar;180(3):597-603. (PMID: 30176057)
      Adv Wound Care (New Rochelle). 2016 Mar 1;5(3):119-136. (PMID: 26989578)
      Mar Drugs. 2020 Dec 21;18(12):. (PMID: 33371308)
      Photochem Photobiol Sci. 2006 Apr;5(4):432-5. (PMID: 16583025)
      Mar Drugs. 2021 Feb 27;19(3):. (PMID: 33673485)
      Mar Drugs. 2015 Oct 20;13(10):6453-71. (PMID: 26492257)
      Enzyme Res. 2011 Mar 08;2011:427285. (PMID: 21423679)
      Mar Drugs. 2020 Sep 22;18(9):. (PMID: 32972038)
      J Pathol. 2007 Jan;211(2):241-51. (PMID: 17200942)
      ACS Chem Biol. 2020 Mar 20;15(3):751-757. (PMID: 31935054)
      Ann N Y Acad Sci. 2007 Nov;1119:40-50. (PMID: 18056953)
      Mol Aspects Med. 2003 Dec;24(6):345-51. (PMID: 14585305)
    • Grant Information:
      CEECIND/01768/2021 Fundação para a Ciência e Tecnologia; UI/BD/150903/2021 Fundação para a Ciência e Tecnologia
    • Contributed Indexing:
      Keywords: UV-blocker; allophycocyanin; beta-carotene; elastase; hyaluronidase; melanin; oxidative-stress; phycocyanin; phycoerythrin; tyrosinase
    • Accession Number:
      0 (Bacterial Proteins)
      0 (Complex Mixtures)
      0 (Cosmetics)
      0 (Free Radical Scavengers)
      0 (Phenols)
      0 (Radiation-Protective Agents)
      11062-77-4 (Superoxides)
      36-88-4 (Carotenoids)
      YF5Q9EJC8Y (Chlorophyll A)
    • Publication Date:
      Date Created: 20220324 Date Completed: 20220331 Latest Revision: 20230308
    • Publication Date:
      20230309
    • Accession Number:
      PMC8950663
    • Accession Number:
      10.3390/md20030183
    • Accession Number:
      35323482